Active specific immunotherapy for colorectal cancer
- 1 October 2003
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 3 (5) , 685-694
Abstract
With advances in molecular biology and the identification of tumor-associated antigens, a number of new strategies have been developed in an attempt to overcome the limits of chemotherapy and to aid in the fight to cure patients of metastatic and micrometastatic colorectal carcinomas. Biological therapy has now moved into the era of immunotherapy. Nonspecific immunotherapy has been surpassed by modalities that produce a specific and potent immune response against identifiable tumor-associated antigens, so called active specific immunotherapy. Approaches that come under this heading include tumor cell vaccines, anti-idiotypic antibody therapy and dendritic cell vaccines. Cells can be further boosted by the use of immunostimulatory cytokines. This review aims to evaluate current strategies of immunotherapy for colorectal cancer with particular emphasis on the clinical aspects.Keywords
This publication has 9 references indexed in Scilit:
- Activated T lymphocytes bindin situ to stromal tissue of colon carcinoma but lack adhesion to tumor cellsEuropean Journal of Immunology, 2001
- Clinical and Immune Responses in Resected Colon Cancer Patients Treated With Anti-Idiotype Monoclonal Antibody Vaccine That Mimics the Carcinoembryonic AntigenJournal of Clinical Oncology, 1999
- Dendritic cells and the control of immunityNature, 1998
- Apoptosis by Death FactorCell, 1997
- Clinical outcome of colorectal cancer patients treated with human monoclonal anti‐idiotypic antibodyInternational Journal of Cancer, 1994
- Costimulation of T cells for tumor immunityImmunology Today, 1993
- APC mutations occur early during colorectal tumorigenesisNature, 1992
- The Cell Biology of Antigen Processing and PresentationAnnual Review of Immunology, 1991
- MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness1979